Titan pharmaceuticals inc (TTNP)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

8,038

5,223

921

2,292

5,909

9,295

8,427

1,614

3,465

7,522

11,688

8,350

10,870

14,006

16,489

19,305

5,762

7,857

9,690

11,499

13,423

15,470

7,450

8,853

10,239

11,798

8,998

11,176

17,606

18,102

5,062

4,104

2,308

5,406

2,772

6,092

3,180

Restricted cash

-

-

0

0

0

361

361

361

361

361

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivables

1,551

993

775

1,140

2,052

1,737

682

189

27

65

91

87

1,009

3,587

5,908

4,851

4,857

4,213

3,898

4,476

3,483

3,968

4,143

3,743

4,080

4,818

4,590

3,851

4,094

4,646

3,530

3,910

3,531

3,720

2,797

1,731

1,225

Inventory

1,064

998

1,309

1,317

1,246

1,262

1,293

1,317

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract assets

-

-

0

0

0

99

195

291

291

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,493

1,094

941

744

882

547

567

421

605

362

277

317

433

237

278

237

370

174

262

238

296

145

266

216

286

204

262

203

265

687

788

805

898

836

899

928

294

Total current assets

12,146

8,308

3,946

5,493

10,089

13,301

11,525

4,193

4,749

8,310

12,056

8,754

12,312

17,830

22,675

24,393

10,989

12,244

13,850

16,213

17,202

19,583

11,859

12,812

14,605

16,820

13,850

15,230

21,965

23,435

9,380

8,819

6,737

9,962

6,468

8,751

4,699

Property and equipment, net

780

817

752

754

782

794

329

424

541

595

684

660

762

837

860

905

1,007

1,043

1,059

1,100

1,186

1,268

1,357

1,437

1,518

1,603

1,670

1,678

1,567

1,392

1,364

1,235

772

255

83

90

53

Operating lease right-of-use asset

336

397

456

514

569

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

13,262

9,522

5,304

6,761

11,440

14,095

11,854

4,617

5,290

8,905

12,740

9,414

13,074

18,667

23,535

25,298

11,996

13,287

14,909

17,313

18,388

20,851

13,216

14,249

16,123

18,423

15,520

16,908

23,532

24,827

10,744

10,054

7,509

10,217

6,551

8,841

4,752

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

1,332

1,401

1,383

1,025

1,204

1,526

686

575

345

821

712

928

1,537

3,015

4,954

4,848

4,258

4,158

4,038

4,786

3,948

4,408

4,362

3,832

4,291

5,118

5,293

4,405

5,039

3,767

4,878

5,405

4,060

4,789

3,026

3,002

2,457

Accrued clinical trials expenses

440

309

434

504

-

620

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued sales allowances

201

809

750

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued clinical trials expenses

-

-

-

-

666

-

453

474

408

289

706

385

189

1,387

1,248

771

379

341

206

121

292

254

173

131

137

118

423

378

1,390

532

650

600

1,308

161

1,357

1,205

705

Accrued sales allowances

-

-

-

-

887

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

1,488

809

653

397

534

466

437

401

556

354

554

556

544

455

516

449

443

354

350

378

340

329

343

364

327

293

306

315

427

219

234

497

519

173

-

-

373

Deferred revenue

-

-

-

0

0

-

626

939

1,409

0

-

-

-

-

-

-

-

-

0

0

760

1,671

2,583

3,494

4,405

5,317

6,228

8,427

10,625

14,375

1,700

-

-

0

-

-

-

Operating lease liability, current

282

272

262

253

243

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

0

830

-

313

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability, current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

931

462

-

-

-

-

-

Current portion of long-term debt

667

0

0

1,333

1,227

527

0

0

0

3,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

0

-

2,500

2,500

2,500

2,500

-

0

2,000

2,000

1,870

Total current liabilities

4,410

3,600

3,482

4,342

4,761

3,452

2,202

2,389

2,718

4,464

1,972

1,869

2,270

4,857

6,718

6,068

5,080

4,853

4,594

5,285

5,340

6,662

7,461

7,821

9,160

10,846

12,250

13,525

19,981

21,393

10,893

9,464

5,887

5,123

6,383

6,207

5,405

Derivative liability

-

-

0

0

25

25

17

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability, non-current

76

150

222

292

357

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,248

-

-

-

-

-

-

-

-

-

-

Royalty liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

8,962

-

-

-

-

-

-

-

Royalty liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,309

-

-

-

Royalty liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,087

9,849

9,476

-

-

-

-

Long-term debt

3,500

4,019

3,872

2,698

3,242

3,787

4,146

3,541

3,418

3,584

6,725

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

9,360

9,618

9,663

12,209

12,253

13,005

12,515

5,400

Warrant liability

0

320

388

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liabilities

-

-

-

-

-

-

-

-

-

-

5

7

197

619

1,555

1,550

1,440

1,444

1,398

10,042

8,857

5,578

1,504

2,965

2,681

1,817

-

1,237

6,599

8,240

7,277

4,073

3,627

3,611

4,713

7,104

-

Total liabilities

7,986

8,089

7,964

7,332

8,385

7,264

6,365

5,930

6,136

8,048

8,702

1,876

2,467

5,476

8,273

7,618

6,520

6,297

5,992

15,327

14,197

12,240

8,965

10,786

11,841

12,663

14,498

14,762

26,580

47,955

37,875

33,049

31,199

30,296

24,101

25,826

10,805

Commitments and contingencies (Note 5)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, $0.001 par value per share; 5,000,000 shares authorized, none issued and outstanding at December 31, 2019 and 2018.

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

Common stock, at amounts paid-in

93

57

17

14

13

13

39

297,855

297,855

4

297,855

297,855

297,855

297,855

297,855

297,855

297,828

297,828

297,828

289,182

289,182

289,196

284,449

284,448

284,485

284,485

279,560

279,560

279,560

265,986

262,052

258,539

256,436

256,436

256,436

256,436

256,436

Additional paid-in capital

359,804

350,413

342,419

341,708

340,138

339,397

334,525

27,577

27,175

324,124

25,794

25,103

24,721

24,300

24,044

23,842

23,593

23,261

22,894

22,802

22,726

22,235

22,149

22,078

22,018

21,692

21,670

21,649

21,519

21,014

20,666

20,301

19,985

18,433

18,064

17,825

17,256

Accumulated deficit

-354,621

-349,037

-345,096

-342,293

-337,096

-332,579

-329,075

-326,745

-325,876

-323,271

-319,611

-315,420

-311,969

-308,964

-306,637

-304,017

-315,945

-314,099

-311,805

-309,998

-307,717

-302,820

-302,347

-303,063

-302,221

-300,417

-300,208

-299,063

-304,127

-310,128

-309,849

-301,835

-300,111

-294,948

-292,050

-291,246

-279,745

Total stockholders' equity

5,276

1,433

-2,660

-571

3,055

6,831

5,489

-1,313

-846

857

4,038

7,538

10,607

13,191

15,262

17,680

5,476

6,990

8,917

1,986

4,191

8,611

4,251

3,463

4,282

5,760

1,022

2,146

-3,048

-23,128

-27,131

-22,995

-23,690

-20,079

-17,550

-16,985

-6,053

Total liabilities and stockholders' equity

13,262

9,522

5,304

6,761

11,440

14,095

11,854

4,617

5,290

8,905

12,740

9,414

13,074

18,667

23,535

25,298

11,996

13,287

14,909

17,313

18,388

20,851

13,216

14,249

16,123

18,423

15,520

16,908

23,532

24,827

10,744

10,054

7,509

10,217

6,551

8,841

4,752